- $194.12m
- $194.24m
- $22.62m
- 63
- 17
- 75
- 51
Annual balance sheet for Tecogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.49 | 3.61 | 1.91 | 1.35 | 5.41 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.9 | 13 | 9.23 | 8.04 | 6.43 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 22.2 | 25 | 22 | 20.3 | 22.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.92 | 3.65 | 2.65 | 2.11 | 3.92 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 30.1 | 32.4 | 28.3 | 27.8 | 31.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.82 | 8.78 | 7.69 | 10.5 | 16.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.8 | 11.2 | 9.16 | 13 | 20.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 17.3 | 21.2 | 19.1 | 14.7 | 10.2 |
| Total Liabilities & Shareholders' Equity | 30.1 | 32.4 | 28.3 | 27.8 | 31.1 |
| Total Common Shares Outstanding |